In this study, we employed GANT61, a small molecule inhibitor of both Gli1 and Gli2 [29], to identify unique downstream targets of the GLI genes that function specifically in cellular migration and invasion in ovarian cancer. The gene discussed is GLI1; the disease is ovarian carcinoma.